Can ADC Be Combined with Bispecific Antibodies?
Introduction In recent years, two major breakthroughs in cancer treatment—Antibody-Drug Conjugates (ADC) and Bispecific Antibodies (referred to as “bispecifics”)—have demonstrated remarkable efficacy. So, if these two “star drugs” are used in combination, will they produce a stronger anti-cancer effect? Will the toxicity be compounded and difficult to control? A recent clinical study published in the … Read more